Katsuto Takenaka

Stem cell gene expression programs influence clinical outcome in human leukemia

Kolja Eppert, Katsuto Takenaka, Eric R. Lechman et al. · Nature Medicine · 2011 · 1K citations

Hematological Malignancy, Cell Therapy, Human Leukemia +11

Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells

Katsuto Takenaka, Tatiana K. Prasolava, Jean Wang et al. · Nature Immunology · 2007 · 486 citations

Induced Pluripotent Stem Cell, Medicine, Genetics +7

TIM-3 Is a Promising Target to Selectively Kill Acute Myeloid Leukemia Stem Cells

Yoshikane Kikushige, Takahiro Shima, Shin‐ichiro Takayanagi et al. · Cell stem cell · 2010 · 475 citations · Full text

Hematological Malignancy, Cell Therapy, Medicine +10

Self-Renewing Hematopoietic Stem Cell Is the Primary Target in Pathogenesis of Human Chronic Lymphocytic Leukemia

Yoshikane Kikushige, Fumihiko Ishikawa, Toshihiro Miyamoto et al. · Cancer Cell · 2011 · 301 citations · Full text

Hematological Malignancy, Medicine, Stem Cell Mobilization +9

A TIM-3/Gal-9 Autocrine Stimulatory Loop Drives Self-Renewal of Human Myeloid Leukemia Stem Cells and Leukemic Progression

Yoshikane Kikushige, Toshihiro Miyamoto, Junichiro Yuda et al. · Cell stem cell · 2015 · 273 citations · Full text

Hematological Malignancy, Cell Therapy, Mixed-phenotype Acute Leukemia +6